[Cost-utility analysis of the introduction of universal infant rotavirus vaccination in Spain]

Imaz I, Cornejo AM, Rubio B, González-Enríquez J
Record ID 32013000270
Spanish
Authors' objectives: To evaluate cost-utility of the introduction of universal infant rotavirus vaccination using RotaTeq® compared to no vaccination in Spain. To assess effect that efficacy and price of the vaccine have on the incremental cost-utility ratio
Authors' recomendations: Based on assumptions and parameters included in the model, the introduction of universal infant rotavirus vaccination using RotaTeq® in Spain would not be efficient. A vaccine price reduction by half could do efficient such a programme. However, increases of vaccine efficacy based on the reported data would not significantly modify the efficiency results.
Details
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Humans
  • Rotavirus Vaccines
  • Spain
  • Cost-Benefit Analysis
Contact
Organisation Name: Agencia de Evaluacion de Tecnologias Sanitarias
Contact Address: Jose Luis de Sancho Martin, Instituto de Salud "Carlos III", Calle Sinesio Delgado 6, Pabellon 4, 28029 Madrid, Spain. Tel: +34 9 1 822 2005; Fax: +34 9 1 387 7841;
Contact Name: jsancho@isciii.es
Contact Email: jsancho@isciii.es
Copyright: Agencia de Evaluacion de Tecnologias Sanitarias (AETS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.